摘要: Numerous clinical trials have shown topical imiquimod (Aldara) to be effective and safe for the treatment of anogenital warts. In addition, recurrence rate appears lower than those reported many standard therapies genital Clinical experience with this medication since its availability 2 years ago has that it is important in therapy disease. However, not ideal all cases, advantages disadvantages individual patients must considered. antiviral antiproliferative effects imiquimod, as well early reports, indicate may prove useful other skin diseases, including some nongenital warts molluscum contagiosum. (J Am Acad Dermatol 2000;43:S12-7.)
jaad.org
elsevier.com
sci-hub.se 参考文章(14)
Alvin E. Friedman-Kien, Natural Interferon Alfa for Treatment of Condylomata Acuminata JAMA: The Journal of the American Medical Association. ,vol. 259, pp. 533- 538 ,(1988) , 10.1001/JAMA.1988.03720040025021
Tanweer A. Syed, Oliver Abbas Ahmadpour, Seyed Ali Ahmad, Seyed Hamzeh Ahmad, Management of Female Genital Warts with an Analog of Imiquimod 2% in Cream: A Randomized, Double‐Blind, Placebo‐Controlled Study Journal of Dermatology. ,vol. 25, pp. 429- 433 ,(1998) , 10.1111/J.1346-8138.1998.TB02429.X
Tanweer A. Syed, Jagdish Goswami, Oliver Abbas Ahmadpour, Seyed Ali Ahmad, Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. Journal of Dermatology. ,vol. 25, pp. 309- 313 ,(1998) , 10.1111/J.1346-8138.1998.TB02403.X
Karl R. Beutner, John K. Geisse, Donita Helman, Terry L. Fox, Angela Ginkeld, Mary L. Owens, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream Journal of The American Academy of Dermatology. ,vol. 41, pp. 1002- 1007 ,(1999) , 10.1016/S0190-9622(99)70261-6
C S Petersen, P Bjerring, J Larsen, J Blaakaer, H Hagdrup, E From, L Obergaard, Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Sexually Transmitted Infections. ,vol. 67, pp. 99- 102 ,(1991) , 10.1136/STI.67.2.99
G Gross, A Roussaki, S Baur, M Wiegand, A Mescheder, Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial. Sexually Transmitted Infections. ,vol. 72, pp. 71- 71 ,(1996) , 10.1136/STI.72.1.71
MICHAEL J. STRAUSS, VIKRAM KHANNA, JACQUELINE D. KOENIG, STEPHEN M. DOWNS, STEVEN H. GOLDBERG, MICHAEL J. MANYAK, BRUCE PATSNER, The cost of treating genital warts International Journal of Dermatology. ,vol. 35, pp. 340- 348 ,(1996) , 10.1111/J.1365-4362.1996.TB03635.X
Libby Edwards, Alex Ferenczy, Lawrence Eron, David Baker, Mary L Owens, Terry L Fox, Andrina J Hougham, Kathy A Schmitt, HPV Study Group, Self-administered Topical 5% Imiquimod Cream for External Anogenital Warts Archives of Dermatology. ,vol. 134, pp. 25- 30 ,(1998) , 10.1001/ARCHDERM.134.1.25
S. K. Tyring, I. Arany, M. A. Stanley, M. A. Tomai, R. L. Miller, M. H. Smith, D. J. McDermott, H. B. Slade, A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod The Journal of Infectious Diseases. ,vol. 178, pp. 551- 555 ,(1998) , 10.1086/517472
Karl R. Beutner, Stephen K. Tyring, Kenneth F. Trofatter, John M. Douglas, Spotswood Spruance, Mary L. Owens, Terry L. Fox, Andrina J. Hougham, Kathy A. Schmitt, Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 789- 794 ,(1998) , 10.1128/AAC.42.4.789